Where Will Eli Lilly Be in 5 Years?
Eli Lilly (NYSE: LLY) is firing on all cylinders. That's not news to anyone paying close attention to the biotech industry, nor is the company a newcomer to success. The drugmaker's stock has crushed the broader market over the past five years.
Here's the million-dollar question, though: Can Eli Lilly keep up the momentum? Past success doesn't guarantee anything, after all. And some investors might fear that they have missed the boat. Perhaps it's too late to invest in Eli Lilly. But is that the case?
Let's find out how things might evolve for the company over the next half-decade.
Source Fool.com